Perrigo Confirms FDA Approval For Testosterone Gel 1%Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo's NDA included a bioequivalence study that compared its product to AbbVie's AndroGel 1%.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen